Table 2 Study participant demographic characteristics
|  | Placebo group (n = 21) | FRG group (n = 21) | p- value1) |
|---|---|---|---|
Sex (M/F) | 15/6 | 13/8 | 0.5132) |
Age (years) | 53.5 ± 1.9 | 53.2 ± 1.8 | 0.914 |
Height (cm) | 165.0 ± 1.8 | 166.6 ± 1.4 | 0.477 |
Weight (kg) | 67.5 ± 2.4 | 68.9 ± 1.8 | 0.646 |
Waist (cm) | 91.1 ± 1.7 | 93.0 ± 1.3 | 0.406 |
BMI (kg/m2) | 24.9 ± 0.8 | 24.9 ± 0.7 | 1.000 |
Fasting plasma glucose (mmol/l) | 6.4 ± 0.6 | 6.5 ± 0.5 | 0.737 |
Total cholesterol (mmol/l) | 4.8 ± 0.1 | 5.2 ± 0.2 | 0.121 |
LDL cholesterol (mmol/l) | 2.9 ± 0.1 | 3.1 ± 0.1 | 0.414 |
HDL cholesterol (mmol/l) | 1.2 ± 0.1 | 1.3 ± 0.1 | 0.170 |
Triglycerides (mmol/l) | 1.7 ± 0.1 | 1.7 ± 0.1 | 0.928 |